Health Canada granted injunction over unauthorized peptide retailer sales
Health Canada has secured a permanent injunction against Canlab Research to stop the sale and promotion of unauthorized injectable peptides. The agency warns that these products pose significant health risks, including hormonal imbalances and organ damage.
Why it matters
This highlights the regulatory challenges of policing online retailers selling unapproved health products that promise performance or anti-aging benefits.
Health Canada has been granted a permanent injunction against Quebec-based online retailer Canlab Research , preventing the company from selling unauthorized injectable peptides in Canada.
The agency states that Canlab Research had been “selling unauthorized peptide drugs on various websites and promoting them with many unproven health claims, despite repeated enforcement actions by Health Canada.”
That comes after consumers were urged not to buy unauthorized injectable peptides from Canlab Research in December 2023 due to the “serious health risks posed by these products” and after a ministerial order “directing the company to cease advertising and selling unauthorized health products because of the health risks to Canadians,” Health Canada stated in a news release on Wednesday.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in